Protalix BioTherapeutics
PLX
#8391
Rank
C$0.25 B
Marketcap
$3.53
Share price
2.10%
Change (1 day)
79.40%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -C$10.4 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$45.66 Million. In 2023 the company made an earning of C$17.07 Million, an increase over its 2022 earnings that were of -C$17.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$10.4 Million-160.87%
2023 C$17.07 M-199.05%
2022 -C$17.24 Million-40.38%
2021 -C$28.92 Million-732.31%
2020 C$4.57 M-130.53%
2019 -C$14.98 Million189.85%
2018 -C$5.17 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$26.89 Million-32.37%
2015 -C$39.76 Million10.11%
2014 -C$36.11 Million-7.59%
2013 -C$39.07 Million
2011 -C$45.25 Million-19.39%
2010 -C$56.13 Million20.87%
2009 -C$46.44 Million32.26%
2008 -C$35.11 Million-5.46%
2007 -C$37.14 Million
2004 -C$0.25 Million12.35%
2003 -C$0.22 Million-11.1%
2002 -C$0.25 Million-57.03%
2001 -C$0.57 Million1.03%
2000 -C$0.56 Million-53.22%
1999 -C$1.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$99.28 Million 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.95 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.08 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.61 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel